In this issue of Healthcare Matters, we are pleased to feature Proven Biotics as our Health & Wellbeing Company of the Month
ProVen Biotics is a research-led brand, supported by more than 30 years of research and development relating to the gut microbiome and the use of probiotics to support its composition and function. Since its inception in 2012, ProVen Biotics has consistently provided product formulations that have undergone rigorous clinical research, demonstrating their efficacy in complementing antibiotic therapies and alleviating symptoms of irritable bowel syndrome (IBS), to name two of the primary areas of research.
As the parent company to ProVen Biotics, Cultech Ltd stands as a renowned global brand, distinguished as a pivotal manufacturer of probiotics serving companies worldwide. With a comprehensive facility, the company ferments its own probiotic strains, oversees manufacturing and packaging of supplements, and orchestrates distribution and marketing across more than 20 countries worldwide.
The company’s aim has always been to produce efficacious products based upon comprehensive primary research and development. Cultech Ltd has been instrumental in supporting ProVen Biotics with its expertise in developing cutting-edge probiotic formulations.
We spoke to Adrienne Benjamin, Registered Nutritionist at ProVen Biotics who explained some of the latest innovative products ProVen has introduced to the market.
“So far in 2024, we have already published two clinical trials and launched two new products, one of which is specifically related to our study on the use of probiotics alongside antibiotics in adults. Our new ATB Intensive product, contains our Lab4 probiotics blend along with a beneficial yeast called Saccharomyces boulardii and is designed to be taken alongside and following a course of antibiotics.”
“In the past couple of years, we have also invested heavily in our own fermentation facility and identified ways to improve our packaging to extend the shelf-life of our products. We are now also offering products with prebiotic and post-biotic ingredients and are in the process of re-branding our range to ProVen Biotics (from ProVen Probiotics) to reflect these changes.”
“We always have a continuous programme of new product development and technological improvement at ProVen, that is generally driven by our clinical research studies and understanding of emerging trends in the industry.”
ProVen’s commitment to quality control throughout the manufacturing process is exceptional. From the start, ProVen was set up to take the best of everything the founders had learned in their previous careers in science and antibiotics and to show people that probiotics really do benefit family health. The two founders are Dr’s Nigel and Sue Plummer, both microbiologists, who established Cultech with a strong ethos of integrating probiotic research and developing innovative new products founded on robust clinical evidence. ProVen’s quality assurance and transparency with its customers is founded upon this evidence base, which supports the efficacy and effectiveness of all ProVen products.
As a clear leader within the probiotics industry, ProVen has shown its commitment to research and development both to support the efficacy of its own probiotic blends and to the development of the probiotics industry as a whole using its own collective understanding of the human microbiome.
“We invest heavily in all kinds of research and have a team of more than 20 research scientists committed to this goal, who work continuously on contributing to industry research (in vitro, in vivo and clinical) and to new product development.”
“We have been researching our Lab4 probiotics blend for more than 20 years and this is the bacteria consortium that we build our ProVen products around. Through our clinical research, we have shown real benefits across multiple conditions and needs using this specific blend – two strains of Lactobacillus acidophilus, Bifidobacterium animalis subsp. lactis and Bifidobacterium bifidum.”
“Most of our products contain this live bacteria blend with other nutrients to support specific health needs, and in the past five years or so we have also studied other key bacteria strains to understand how these strains might further enhance our clinical results.”
“One key strain that we have used is Lactobacillus plantarum, which we combined with the Lab4 consortium in our ShapeLine product and, more recently, we have undertaken research combining Lab4 with a well-researched beneficial yeast, known as Saccharomyces boulardii,” stated Adrienne.
Furthermore, we are committed to developing products for specific life stages, including menopause, a natural part of aging, the symptoms and health risks associated with which can vary widely among women. In the past year, we have been working to identify ways it can add value to our products to support women going through this transition and have developed our Menopause Plans – Rebel and Rebel Up. By offering these free with bundles of some of their physical products, ProVen work to help educate customers on the importance of gut health in supporting general health – in this case, to support women with aging and hormonal health.
One recent satisfied customer was Jennifer Stoute, a two-time-Olympian and ex-TV Gladiator, who discovered ProVen products and approached the company wanting to work with them after she had been taking them for a year and found they had worked well for her. Jennifer is now part of the inspiration behind the ‘Menopause Rebel’ plans.
ProVen’s brand reputation, market success and considerable R&D investments have already demonstrated the growth and success of the company, but there is still so much more to come. Adrienne explained:
“We are constantly investing in research and new product development and, as a result, we have grown our brand into a significant force internationally. ProVen products are now available throughout the world, including the USA, China, Hong Kong, South Africa, Ireland, Spain, the Baltics, Scandinavia and the Netherlands, and we are moving into more new markets each year.”
“A key part of our brand culture is to continuously innovate from both a manufacturing process and a product development perspective. We now control the supply chain from bacterial strain fermentation to finished product production and we will continue to develop new product lines and innovative approaches to probiotic delivery to support health outcomes.”
For more information, please see below:
https://provenbiotics.uk